Unité de Fabrication des Médicaments S.A reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TND 61.25 million compared to TND 42.48 million a year ago. Revenue was TND 61.3 million compared to TND 42.49 million a year ago.

Net income was TND 6.68 million compared to TND 1.39 million a year ago. Basic earnings per share from continuing operations was TND 0.209 compared to TND 0.043 a year ago.